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Seek medical attention for any chronic cough or shortness of breath, which may indicate chronic beryllium disease.
Seek medical attention for any rash or nonhealing cut or wound.
What Employers Should Do
NIOSH recommends that employers of workers exposed to particles, fumes, mists, or solutions from beryllium-containing materials take the following steps to protect workers, contractors, and visitors:
Know the beryllium content of all materials in the workplace. The manufacturers or suppliers of materials containing greater than 0.1% beryllium are required to provide this information on Material Safety Data Sheets.
Substitute less hazardous materials for those containing beryllium whenever feasible.
Minimize the number of workers exposed to beryllium dusts, fumes, mists, and berylliumcontaining solutions and suspensions.
Install, use, and maintain effective engineering controls for processes that create beryllium dusts, fumes, mists, and beryllium-containing solutions and suspensions.
Keep airborne concentrations of beryllium as low as possible, since a safe exposure limit for beryllium has not been determined.
Monitor airborne beryllium concentrations to document the effectiveness of efforts to reduce airborne exposures.
Inform workers about the risks of beryllium sensitization, chronic beryllium disease, and lung cancer, and the proper procedures for working with beryllium-containing materials.
Keep beryllium dusts, fumes, mists, and beryllium-containing solutions and suspensions confined to the immediate work area.
Do not use cleaning methods that may cause dust to become resuspended in air (dry sweeping, compressed air, and other dust-generating methods, for example). Better methods include HEPA-filtered vacuums or wet cleaning methods that do not produce splash or spray.
Prevent beryllium dusts and other contaminants from leaving beryllium work areas on workers' skin, clothing, shoes, and tools.
Identify and clean areas outside the beryllium work zone that may have become contaminated before these recommendations were implemented.
Establish and maintain an appropriate respiratory protection program as needed.
Establish and maintain a skin protection program to protect workers' skin from contamination with beryllium dusts and solutions:
-Keep work surfaces and work areas clean.
-Provide work gloves, long-sleeved shirts, long pants, and shoes that remain at the workplace.
-Provide showering and changing facilities.
Conduct medical surveillance for sensitization using the beryllium lymphocyte proliferation test for workers who come in contact with beryllium dusts, fumes, mists, and berylliumcontaining solutions and suspensions:
-Identify higher-risk jobs and processes to prioritize prevention efforts and evaluate their effectiveness in decreasing the risk of sensitization.
-Ensure that sensitized workers identified through surveillance are referred for medical testing (1) to determine whether they have chronic beryllium disease, (2) to establish radiographic and lung function baselines for follow-up testing, and (3) receive counseling. Conozca los riesgos y siga todos los procedimientos adecuados para trabajar con berilio (como participar en cursos sobre seguridad).
Evite que el berilio se introduzca en sus pulmones:
-Asegúrese de que haya un control en las fuentes de polvo, emisiones, vapores, soluciones y suspensiones que contienen berilio.
-Participe en programas de protección respiratoria cuando se lo indiquen.
Evite el contacto de la piel con el polvo y las soluciones que contienen berilio:
¡ADVERTENCIA!
Los trabajadores expuestos a partículas, emisiones, vapores o soluciones de materiales que contienen berilio pueden presentar sensibilización al berilio o enfermedad crónica por berilio, que es una afección respiratoria potencialmente discapacitante o incluso mortal.
-Mantenga limpias las superficies y las áreas de trabajo.
-Participe en los programas de protección de la piel. Estos programas pueden incluir el uso de guantes y ropa proporcionados por la empresa (de mangas largas y con pantalones largos) y tener que ducharse al final de la jornada laboral.
No guarde ni consuma alimentos, bebidas, productos de tabaco o cosméticos en áreas donde se trabaja con berilio.
No utilice métodos de limpieza que puedan causar que el polvo vuelva a suspenderse en el aire (por ejemplo, barrido en seco, aire comprimido y otros métodos que producen polvo). Los mejores métodos incluyen las aspiradoras con filtro HEPA o métodos de limpieza húmedos que no salpican ni rocían.
Evite que el polvo de berilio y otros contaminantes salgan de las áreas donde se trabaja con berilio a través de su piel, ropa, zapatos y herramientas.
Participe en la vigilancia médica del lugar de trabajo para que los riesgos relacionados con las tareas del trabajo se puedan identificar y prevenir.
Busque atención médica para cualquier tos crónica o dificultad para respirar, que puede indicar la presencia de la enfermedad crónica por berilio.
Busque atención médica para cualquier irritación en la piel o heridas o cortes que no se curan. Vigile las concentraciones aéreas de berilio con el fin de poder documentar la eficacia de los esfuerzos para reducir las exposiciones aerotransportadas.
Informe a los trabajadores sobre los riesgos de sensibilización al berilio, enfermedad crónica por berilio y cáncer de pulmón, y los proce-dimientos adecuados para trabajar con materiales que contienen berilio.
Mantenga el polvo, las emisiones y los vapores de berilio y las soluciones y suspensiones que contienen berilio dentro del espacio de la zona de trabajo inmediata.
Evite que el polvo de berilio y otros contaminantes se transporten fuera de las áreas donde se trabaja con berilio a través de la piel, la ropa, los zapatos y las herramientas de los trabajadores.
Identifique y limpie las áreas fuera de la zona de trabajo con el berilio que puedan haberse contaminado antes de que estas recomendaciones fuesen implementadas.
Establezca y mantenga un programa de protección respiratoria adecuado cuando sea ne-cesario.
Establezca y mantenga un programa de protección de la piel para proteger a los trabajadores de la contaminación con polvo y soluciones con berilio:
-Proporcione guantes de trabajo, camisas de manga larga, pantalones largos y zapatos que permanezcan en el lugar de trabajo.
-Proporcione espacio para ducharse y vestuarios.
Lleve a cabo un programa de vigilancia médica para detectar la sensibilización al berilio con la prueba de proliferación de linfocitos por berilio para los trabajadores que están en contacto el polvo, las emisiones, los vapores, las soluciones y suspensiones que contienen berilio:
-Identifique los puestos de trabajo y los procesos de alto riesgo para dar prioridad a los esfuerzos de prevención y evaluar su eficacia en la disminución del riesgo de sensibilización.
-Asegúrese de que se remita a los trabajadores sensibilizados identificados a través del programa de vigilancia para realizarse análisis médicos (1) para determinar si tienen la enfermedad crónica por berilio, (2) para establecer una referencia radiológica y del funcionamiento respiratorio para las pruebas de seguimiento y (3) recibir asesoramiento. 
BACKGROUND
Risks may be associated with all berylliumcontaining materials (including alloys of beryllium as well as beryllium metal and oxide materials) when these materials are heated or worked to create particles, fumes, or mists.
Beryllium may be encountered as any of the following:
Compounds extracted from beryl and bertrandite minerals A refined metal with unique physical properties including high strength, lightness (low density), stiffness, dimensional stability, fidelity of vibration transmission, high thermal and electrical conductivity, neutron-moderating properties, and X-ray transparency A ceramic with electrical resistivity, a high melting point, and excellent thermal conductivity WARNING! Workers exposed to particles, fumes, mists, or solutions from beryllium-containing materials may develop beryllium sensitization or chronic beryllium disease, a potentially disabling or even fatal respiratory disease.
The National Institute for Occupational Safety and Health (NIOSH) requests assistance in preventing beryllium sensitization and chronic beryllium disease. Development of these conditions requires exposure to beryllium and is affected by both job tasks and genetic factors. Some jobs or tasks involve exposures that increase the risk of sensitization and disease. Some people have inherited genes that make them more likely to become sensitized or develop chronic beryllium disease when exposed.
NIOSH requests that the information in this Alert be brought to the attention of workers and employers by the following: trade associations, editors of trade journals, safety and health officials, labor organizations, members of the academic and public health communities, advocacy groups, workers' compensation insurance companies, manufacturers and distributors of materials that contain beryllium, and the mass media. 
BERYLLIUM SENSITIZATION
A worker's immune system determines whether he or she will develop health problems from working with beryllium. Some workers become sensitized to beryllium, which means that exposure to beryllium has triggered the immune system to recognize and *Copper-beryllium alloys are the most widely used form of beryllium.
respond to this metal as a foreign substance. No health symptoms are associated with beryllium sensitization. However, it is believed that a person must first be sensitized before beryllium in the lungs can cause the lung damage (called granulomas) of chronic beryllium disease [1] .
Some individuals identified as sensitized with the BeLPT will already have chronic beryllium disease [2] . Those who are sensitized without chronic beryllium disease are at increased risk of developing it in the future. In one study following 55 sensitized individuals without chronic beryllium disease, about 1/3 were diagnosed with the disease within a 4½ year period of follow-up [3] . However, the overall proportion of all sensitized individuals who will eventually develop chronic beryllium disease is not known.
DISEASES Chronic Beryllium Disease
Chronic beryllium disease occurs when a sensitized worker's lungs react with beryllium that has been inhaled, producing lung granulomas and scarring.
To determine whether chronic beryllium disease is present, workers with abnormal BeLPT results must have further medical testing. A lung biopsy may be performed to remove small samples of lung tissue. In chronic beryllium disease, granulomas can be seen with a microscope in the biopsy samples. The biopsy test can detect disease before a worker has any symptoms. A lung lavage, where cells are "washed" from the lung, may also be performed and the lavage cells tested for sensitization. Other tests such as chest X-rays, computed axial tomography (CAT) scans of the chest, and pulmonary function tests can also help make the diagnosis of advanced disease.
Chronic beryllium disease has been observed among workers with a variety of exposure histories -long and short duration, high and low air concentrations of beryllium, and any form of beryllium. In many cases, chronic beryllium disease develops while workers are still being exposed to beryllium, occasionally within months of first exposure. In other instances, the disease may not be diagnosed until years after a person has stopped working in the beryllium industry.
Chronic beryllium disease usually has a slow onset of symptoms. It can be so mild at the time of diagnosis that the affected worker has no suspicion that he or she has a lung disease. However, when chronic beryllium disease progresses, the widespread granulomas and associated lung damage cause chronic chest symptoms such as coughing and shortness of breath on exertion. Other symptoms that may develop in some persons with chronic beryllium disease are unusual fatigue, night sweats, and weight loss.
The symptoms and lung function abnormalities often respond to corticosteroid medication such as prednisone or other medications that suppress the immune system response to beryllium. However, these medications do not cure the disease; they have side effects and must usually be taken indefinitely to prevent progressive lung damage or slow the rate of clinical deterioration. Some people with chronic beryllium disease eventually require supplemental oxygen, become severely disabled, and even die because of respiratory failure or insufficiency.
Certain genes appear to cause some beryllium-exposed workers to be more susceptible to beryllium sensitization and chronic beryllium disease [2] . Continuing genetic research may contribute to a better understanding of why some are more susceptible. This research may also lead to prevention of sensitization and disease and the exploration of new treatments for sensitization and disease in affected workers. However, with our current knowledge, genetic testing is not useful in predicting who will develop chronic beryllium disease because (1) the genes linked to sensitization and disease are found in a large percentage of the general population, and (2) sensitization and chronic beryllium disease have developed in some people who do not have these genes. The future usefulness of genetic testing remains to be determined, but it may someday have a role in helping workers make informed decisions about working with beryllium.
Acute Beryllium Disease
Acute beryllium disease has been diagnosed in the past, but it is rare today. The disease typically has a quick onset with symptoms resembling those of pneumonia or bronchitis. It occurs after exposure to soluble beryllium salts, which are used in the making of beryllium metal. Acute beryllium disease usually resolves within months of stopping beryllium work, but some affected workers later develop chronic beryllium disease.
Cancer
Significantly elevated risks of lung cancer have been reported for workers exposed to beryllium; the National Toxicology Program lists it as a known carcinogen [4] and the International Agency for Research on Cancer reaffirmed its classification as carcinogenic to humans [5] . Controlling beryllium exposures to prevent chronic beryllium disease should also reduce the risk for lung cancer.
MEDICAL SURVEILLANCE
Medical surveillance of a workforce looks at medical test results over time in relation to information about jobs and processes. Medical surveillance of workers exposed to beryllium includes using the BeLPT to identify sentinel (new) cases of sensitization. Identification of sentinel cases may indicate that co-workers are at risk. Surveillance information is used to determine whether some jobs or processes are higher risk than others, to set priorities for making changes to protect workers, and to evaluate the success of efforts to prevent disease. Testing for beryllium sensitization is not a substitute for prevention of beryllium exposure and may not prevent chronic beryllium disease in sensitized individuals.
WORKFORCE SURVEYS
Since the late 1980s, beryllium-exposed workforces have been surveyed for sensitization to beryllium and chronic beryllium disease. Workers typically complete a questionnaire about their health and work history and submit blood samples that are tested for sensitization to beryllium. Sensitized workers are then further evaluated for chronic beryllium disease. Scientists look for jobs and work tasks in which sensitization and chronic beryllium disease are most common. They may also estimate workers' beryllium exposure to determine whether risk increases as estimated exposure increases.
Researchers have studied various beryllium workplaces, including those in the primary beryllium industry, nuclear weapons facilities, the ceramics industry, mining and ore milling facilities, precision machining plants, beryllium-contaminated buildings undergoing decontamination and decommissioning, workplaces with construction trades workers, and aluminum smelters [1, [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . Workers in these studies were exposed to different forms of beryllium, such as beryllium oxide ceramic, pure beryllium metal, and beryllium alloys (primarily copper alloys); they may have been current or former workers.
Workers who refine, prepare, and process beryllium and beryllium-containing materials are at the greatest risk for sensitization and chronic beryllium disease. Sensitization has been found in 1% to 15% of workers studied cross-sectionally, with chronic beryllium disease diagnosed in 10% to 100% of sensitized workers [2] . In one longitudinal study of a beryllium oxide ceramics worker cohort, the 11-year prevalences of sensitization and chronic beryllium disease were 20% and 14%, respectively [15] . The risk for workers in other industries depends on their potential exposure to dust particles, fumes, mists, and beryllium-containing solutions and suspensions.
Exposure-Related Risks
Some production jobs have higher rates of sensitization or chronic beryllium disease. Specific jobs or work processes that have been shown to carry a higher risk include machining of ceramics or beryllium metal, ceramics production, work with copper-beryllium rod and wire materials, and engineering, laboratory, and technical jobs [1, 7-10, 14, 17] .
Risk is not limited to production workers. In many studies, additional cases of sensitization or chronic beryllium disease were identified among nonproduction workers or workers whose exposure appeared to be minimal, such as secretaries, other clerical workers, and security guards [1, [8] [9] [10] 17] .
When estimates of beryllium exposure (based on mass concentration of airborne beryllium) were calculated for study participants, no consistent relationship was found between airborne exposure and risk of either sensitization or chronic beryllium disease. In other words, workers with the highest estimated beryllium exposures were not necessarily at the highest risk, and higher risk jobs or processes did not always have the highest beryllium exposure. Other exposure factors may also be important, including chemical form and particle size [20, Chapter 2] . However, control of airborne beryllium exposure is an important part of any workplace program to reduce the risk of sensitization and chronic beryllium disease.
Skin Exposure
Research suggests that sensitization may result from skin contact with beryllium dusts, fumes, and beryllium-containing solutions and suspensions. In the 1950s, patch testing led to skin sensitization [21] . More recently, researchers observed that tight control of airborne beryllium exposure alone did not prevent sensitization of new workers in the first year or two of their employment [7] . Laboratory researchers demonstrated that (1) mice could become sensitized to beryllium if beryllium was placed on their skin, and (2) tiny particles (dextran beads less than 1 micrometer (µm) in diameter) could penetrate intact human skin tissue samples when the skin was flexed, thereby allowing them to reach the layers of the skin where the immune system cells are located and where the sensitization process can begin [22] . Particles larger than 1 µm could penetrate only cuts or abrasions. Although research is continuing, NIOSH recommends that employers and workers prevent skin contact with beryllium particles or solutions containing beryllium, including protecting skin cuts and abrasions.
Prevention
One study at a beryllium oxide ceramics plant has shown that a comprehensive preventive program can reduce the development of sensitization in new workers not previously exposed to beryllium [23] . The program placed special emphasis on preventing the migration of dust and fluids away from work processes and on protection of skin, in addition to engineering controls and respiratory protection [24] . The facility used medical surveillance with the BeLPT to monitor the effectiveness of the program in preventing sensitization. Nine percent of workers hired between 1993 and 1998, before the program started, became sensitized. Only 1% of workers hired between 2000 and 2004, after the program began, became sensitized. Air levels of beryllium were similar for the two time periods. Since these prevention results are from a single plant and cover a relatively short period of time, the results should be considered encouraging but preliminary. Additional follow-up over longer periods and at other beryllium workplaces remains to be performed.
CASE STUDIES Case 1
Two years after starting work at a berylliumusing facility, a secretary was moved to an area in which beryllium laboratory testing had been done years earlier.
The following year, her work area was renovated, including opening the ventilation duct work. She developed skin problems, including itching and raised lesions, which she believed were due to the dust from renovation. Five months after renovation, she had her first abnormal BeLPT blood test which was confirmed the following month. She was then evaluated for chronic beryllium disease: no granulomas or other abnormalities were found in lung biopsy samples; her lung lymphocytes (obtained through lavage) were elevated (22%); and testing of her lung lavage cells did not indicate lung sensitization. She left work the following year. A second medical evaluation, 16 months after the first, then found granulomas in the biopsy samples and further elevation of lung lavage lymphocytes (36%). At that time she was diagnosed with chronic beryllium disease.
Case 2
A beryllium worker took part in medical surveillance after spending more than 20 years in different production jobs and as a foreman. He did not wear a respirator. He reported no cough, wheeze, or shortness of breath. His first blood samples were sent to two laboratories, and one BeLPT was abnormal. The following month, a second set of samples was sent to two laboratories, and both were abnormal, confirming that he was sensitized. His medical evaluation showed granulomas in his lung biopsy samples, elevated lung lavage lymphocytes (27%), and an abnormal lung lavage BeLPT, all of which supported the diagnosis of chronic beryllium disease. His participation in medical surveillance, along with other workers', contributed to the development of a more comprehensive preventive program at his facility.
What do these cases illustrate? Case 1 shows us that sometimes those who don't work directly with beryllium, but who are exposed to beryllium-containing dust, can develop chronic beryllium disease. It also shows that continued monitoring of the health of sensitized workers is important; this person's chronic beryllium disease was not diagnosed until her second medical evaluation and after she left employment. Case 2 shows us the value of participating in workplace medical surveillance. This person had no symptoms and would not have known he had chronic beryllium disease if he had not participated in the medical surveillance that was offered to him. His participation helped to guide efforts to protect his fellow workers, as well as future workers.
CURRENT EXPOSURE LIMITS
Current beryllium exposure limits and action levels from various agencies and groups are provided below.
NIOSH
In 1977, NIOSH suggested a REL of 0.5 μg/m 3 to reduce the risk of beryllium-related lung cancer [25] . This REL does not prevent beryllium sensitization or chronic beryllium disease. Since a safe exposure limit for beryllium has not been determined, NIOSH recommends that employers keep airborne concentrations of beryllium as low as possible.
OSHA
The current OSHA PEL for beryllium is 2.0 μg/m 3 as an 8-hour time-weighted average (TWA) [26] . OSHA has stated that the current PEL may not adequately protect berylliumexposed workers from developing chronic beryllium disease [27, 28] . Other OSHA exposure limits for beryllium are a ceiling concentration of 5.0 μg/m 3 , and a maximum peak concentration of 25.0 μg/m 3 for a maximum duration of 30 minutes [26] .
DOE
The U.S. Department of Energy (DOE) requires various actions to limit exposures to beryllium (including engineering and administrative controls and the use of respiratory protection). The DOE also requires medical surveillance using the BeLPT to be offered when airborne concentrations of beryllium exceed an action level. In 1999, the DOE set a beryllium exposure action level (8-hour TWA) of 0.2 µg/m 3 [26] . In addition, the DOE building-surface contamination level for beryllium in work areas during nonoperational periods is 3.0 µg/100 cm 2 of surface area. The concentration of beryllium on items released to the public must not exceed 0.2 µg/100 cm 2 [26] . These surface contamination levels are based on technical feasibility rather than on documented risk for sensitization and disease.
-Participate in skin protection programs. These programs may include wearing gloves and company-issued clothing (with long sleeves and long pants) and showering at the end of the workday.
Do not store or consume food, drinks, tobacco products, or cosmetics in beryllium work areas.
Do not use cleaning methods that may cause dust to become resuspended in air (dry sweeping, compressed air, and other dust-generating methods, for example).
Better methods include HEPA-filtered vacuums or wet cleaning methods that do not produce splash or spray.
Prevent beryllium dusts and other contaminants from leaving beryllium work areas on your skin, clothing, shoes, and tools.
Participate in workplace medical surveillance so that risks related to job tasks can be identified and prevented.
Seek medical attention for any rash or non-healing cut or wound.
Minimize the number of workers exposed to beryllium dusts, fumes, mists, and beryllium-containing solutions and suspensions.
Inform workers about the risks of beryllium sensitization, chronic beryllium disease, and lung cancer, and the proper procedures for working with berylliumcontaining materials.
Conduct medical surveillance for sensitization using the beryllium lymphocyte proliferation test for workers who come in contact with beryllium dusts, fumes, mists, and beryllium-containing solutions and suspensions:
-Ensure that sensitized workers identified through surveillance are referred for medical testing (1) to determine whether they have chronic beryllium disease, (2) to establish radiographic and lung function baselines for followup testing, and (3) receive counseling.
